MAP 2026 brings together researchers, clinicians, and molecular diagnostics experts to explore the latest developments in precision oncology. The meeting highlights cutting-edge research, translational science, and innovative approaches transforming cancer care.
Introducing duet mosaic™
biomodal is also excited to introduce the newly launched duet mosaic™ family, new workflows designed for cfDNA and liquid biopsy research that combine genetic, epigenetic, and fragmentomic information from the same molecules, including short, damaged fragments other workflows may miss. When your sample is limited, every fragment matters, and duet mosaic helps researchers access more from every molecule.
👉 Want to connect at the Conference – or sooner? Schedule time with Leonardo by completing the form below and let’s start the conversation.